Stereotactic radiosurgery for brain and spine metastases

被引:5
作者
Bowden, Patrick J. [1 ,2 ]
See, Andrew W. [1 ,2 ]
Daily, Michael J. [1 ,3 ]
Bittar, Richard G. [1 ,2 ,4 ,5 ]
机构
[1] Epworth Healthcare, Melbourne, Vic, Australia
[2] Brain & Spine Tumour Clin, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic 3004, Australia
[4] Royal Melbourne Hosp, Dept Neurosurg, Melbourne, Vic, Australia
[5] Deakin Univ, Fac Hlth, Melbourne, Vic, Australia
关键词
Brain; Metastasis; Radiosurgery; Radiotherapy; Spine; Stereotactic radiosurgery; Tumour; SURGICAL RESECTION; RADIATION-THERAPY; BODY RADIOTHERAPY; CORD COMPRESSION; MANAGEMENT; CANCER; MELANOMA; SURGERY; CAVITY; TRIAL;
D O I
10.1016/j.jocn.2013.07.043
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Metastases to the brain and spine are common and difficult to treat. Stereotactic radiosurgery (SRS) is a non-invasive treatment option for some individuals, and may obviate the need for open surgery and/or whole brain radiotherapy. Over the past decade there has been an increased number of patients undergoing SRS for the treatment of metastatic disease, and multiple published studies show favourable results in terms of local disease control. We review the available literature pertaining to the application of SRS for the treatment of brain and spine metastases, together with its limitations and outcomes. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:731 / 734
页数:4
相关论文
共 40 条
[1]   Clinical accuracy of ExacTrac intracranial frameless stereotactic system [J].
Ackerly, T. ;
Lancaster, C. M. ;
Geso, M. ;
Roxby, K. J. .
MEDICAL PHYSICS, 2011, 38 (09) :5040-5048
[2]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[3]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[4]  
ASAI A, 1989, CANCER-AM CANCER SOC, V63, P1962, DOI 10.1002/1097-0142(19890515)63:10<1962::AID-CNCR2820631016>3.0.CO
[5]  
2-V
[6]   Stereotactic radiosurgery - an organized neurosurgery-sanctioned definition [J].
Barnett, Gene H. ;
Linskey, Mark E. ;
Adler, John R. ;
Cozzens, Jeffrey W. ;
Friedman, William A. ;
Heilbrun, M. Peter ;
Lunsford, L. Dade ;
Schulder, Michael ;
Sloan, Andrew E. .
JOURNAL OF NEUROSURGERY, 2007, 106 (01) :1-5
[7]   Evidence-Based Guidelines for the Management of Brain Metastases [J].
Bhangoo, Sandeep S. ;
Linskey, Mark E. ;
Kalkanis, Steven N. .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2011, 22 (01) :97-+
[8]   Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases Clinical article [J].
Boehling, Nicholas S. ;
Grosshans, David R. ;
Allen, Pamela K. ;
McAleer, Mary F. ;
Burton, Allen W. ;
Azeem, Syed ;
Rhines, Laurence D. ;
Chang, Eric L. .
JOURNAL OF NEUROSURGERY-SPINE, 2012, 16 (04) :379-386
[9]   Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].
Chang, Eric L. ;
Wefel, Jeffrey S. ;
Hess, Kenneth R. ;
Allen, Pamela K. ;
Lang, Frederick F. ;
Kornguth, David G. ;
Arbuckle, Rebecca B. ;
Swint, J. Michael ;
Shiu, Almon S. ;
Maor, Moshe H. ;
Meyers, Christina A. .
LANCET ONCOLOGY, 2009, 10 (11) :1037-1044
[10]   Palliative radiotherapy trials for bone metastases: A systematic review [J].
Chow, Edward ;
Harris, Kristin ;
Fan, Grace ;
Tsao, May ;
Sze, Wai M. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1423-1436